Protein tyrosine nitration of aldolase in mast cells: A plausible pathway in nitric oxide-mediated regulation of mast cell function

Journal of Immunology

Volumn 185, Issue 1, 2010, Pages 578-587

  Sekar, Yokananth ^a   Moon, Tae Chul ^a   Slupsky, Carolyn M ^a   Befus, A Dean ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; FRUCTOSE 1,6 BISPHOSPHATE; FRUCTOSE BISPHOSPHATE ALDOLASE; LACTIC ACID; NITRIC OXIDE; NITRIC OXIDE DONOR; PYRUVIC ACID; S NITROSOGLUTATHIONE; 3 NITROTYROSINE; 3-NITROTYROSINE; DRUG DERIVATIVE; TYROSINE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; GLYCOLYSIS; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MAST CELL; NITRATION; PRIORITY JOURNAL; WESTERN BLOTTING; CELL CULTURE; DEGRANULATION; DRUG ANTAGONISM; ENZYME SPECIFICITY; ENZYMOLOGY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL DEGRANULATION; CELL LINE, TUMOR; CELLS, CULTURED; FRUCTOSE-BISPHOSPHATE ALDOLASE; GLYCOLYSIS; HUMANS; IMMUNOPHENOTYPING; MAST CELLS; NITRIC OXIDE; NITRIC OXIDE DONORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; S-NITROSOGLUTATHIONE; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TYROSINE;

EID: 77956195960     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902720     Document Type: Article

References (92)

1. Moon, T. C., C. D. St Laurent, K. E. Morris, C. Marcet, T. Yoshimura, Y. Sekar, and A. D. Befus. 2010. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol. 3: 111-128.
2. Marshall, J. S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4: 787-799.
3. Galli, S. J., S. Nakae, and M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6: 135-142.
4. Swindle, E. J., and D. D. Metcalfe. 2007. The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes. Immunol. Rev. 217: 186-205.
5. Bidri, M., F. Féger, S. Varadaradjalou, N. Ben Hamouda, J. J. Guillosson, and M. Arock. 2001. Mast cells as a source and target for nitric oxide. Int. Immunopharmacol. 1: 1543-1558.
6. Gilchrist, M., S. D. McCauley, and A. D. Befus. 2004. Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood 104: 462-469.
7. McCauley, S. D., M. Gilchrist, and A. D. Befus. 2005. Nitric oxide: a major determinant of mast cell phenotype and function. Mem. Inst. Oswaldo Cruz 100 (Suppl. 1): 11-14.
8. Forsythe, P., M. Gilchrist, M. Kulka, and A. D. Befus. 2001. Mast cells and nitric oxide: control of production, mechanisms of response. Int. Immunopharmacol. 1: 1525-1541.
9. Gilchrist, M., M. Savoie, O. Nohara, F. L. Wills, J. L. Wallace, and A. D. Befus. 2002. Nitric oxide synthase and nitric oxide production in in vivo-derived mast cells. J. Leukoc. Biol. 71: 618-624.
10. Gilchrist, M., and A. D. Befus. 2008. Interferon-gamma regulates chemokine expression and release in the human mast cell line HMC1: role of nitric oxide. Immunology 123: 209-217.
11. Yip, K. H., Y. Huang, M. M. Waye, and H. Y. Lau. 2008. Induction of nitric oxide synthases in primary human cultured mast cells by IgE and proinflammatory cytokines. Int. Immunopharmacol. 8: 764-768.
12. Coleman, J. W. 2002. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin. Exp. Immunol. 129: 4-10.
13. Nohara, O., M. Kulka, R. E. Déry, F. L. Wills, N. S. Hirji, M. Gilchrist, and A. D. Befus. 2001. Regulation of CD8 expression in mast cells by exogenous or endogenous nitric oxide. J. Immunol. 167: 5935-5939.
14. Bissonnette, E. Y., C. M. Hogaboam, J. L. Wallace, and A. D. Befus. 1991. Potentiation of tumor necrosis factor-alpha-mediated cytotoxicity of mast cells by their production of nitric oxide. J. Immunol. 147: 3060-3065.
15. Moon, T. C., and A. D. Befus. 2008. Exogenous nitric oxide regulates cyclooxygenase-2 expression and prostaglandin D(2) generation through p38 MAPK in mouse bone marrow-derived mast cells. Free Radic. Biol. Med. 45: 780-788.
16. Ischiropoulos, H., and A. Gow. 2005. Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology 208: 299-303.
17. Gow, A. J., C. R. Farkouh, D. A. Munson, M. A. Posencheg, and H. Ischiropoulos. 2004. Biological significance of nitric oxide-mediated protein modifications. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L262-L268.
18. Koeck, T., D. J. Stuehr, and K. S. Aulak. 2005. Mitochondria and regulated tyrosine nitration. Biochem. Soc. Trans. 33: 1399-1403.
19. Szabó, C., H. Ischiropoulos, and R. Radi. 2007. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6: 662-680.
20. Schopfer, F. J., P. R. Baker, and B. A. Freeman. 2003. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends Biochem. Sci. 28: 646-654.
21. Souza, J. M., G. Peluffo, and R. Radi. 2008. Protein tyrosine nitration - functional alteration or just a biomarker? Free Radic. Biol. Med. 45: 357-366.
22. Abello, N., H. A. Kerstjens, D. S. Postma, and R. Bischoff. 2009. Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins. J. Proteome Res. 8: 3222-3238.
23. Kim, J. Y., K. H. Lee, B. K. Lee, and J. Y. Ro. 2005. Peroxynitrite modulates release of inflammatory mediators from guinea pig lung mast cells activated by antigen-antibody reaction. Int. Arch. Allergy Immunol. 137: 104-114.
24. Kirshenbaum, A. S., C. Akin, Y. Wu, M. Rottem, J. P. Goff, M. A. Beaven, V. K. Rao, and D. D. Metcalfe. 2003. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk. Res. 27: 677-682.
25. Moon, T. C., E. Lee, S. H. Baek, M. Murakami, I. Kudo, N. S. Kim, J. M. Lee, H. K. Min, N. Kambe, and H. W. Chang. 2003. Degranulation and cytokine expression in human cord blood-derived mast cells cultured in serum-free medium with recombinant human stem cell factor. Mol. Cells 16: 154-160.
26. Kambe, N., M. Kambe, H. W. Chang, A. Matsui, H. K. Min, M. Hussein, C. A. Oskerizian, J. Kochan, A. A. Irani, and L. B. Schwartz. 2000. An improved procedure for the development of human mast cells from dispersed fetal liver cells in serum-free culture medium. J. Immunol. Methods 240: 101-110.
27. Askew, S. C., A. R. Butler, F. W. Flitney, G. D. Kemp, and I. L. Megson. 1995. Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione. Bioorg. Med. Chem. 3: 1-9.
28. Gordge, M. P., J. S. Hothersall, and A. A. Noronha-Dutra. 1998. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Br. J. Pharmacol. 124: 141-148.
29. Koranteng, R. D., R. J. Dearman, I. Kimber, and J. W. Coleman. 2000. Phenotypic variation in mast cell responsiveness to the inhibitory action of nitric oxide. Inflamm. Res. 49: 240-246.
30. Davis, B. J., B. F. Flanagan, A. M. Gilfillan, D. D. Metcalfe, and J. W. Coleman. 2004. Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells. J. Immunol. 173: 6914-6920.
31. Forsythe, P., and A. D. Befus. 2003. Inhibition of calpain is a component of nitric oxide-induced down-regulation of human mast cell adhesion. J. Immunol. 170: 287-293.
32. Chazotte-Aubert, L., P. Hainaut, and H. Ohshima. 2000. Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells. Biochem. Biophys. Res. Commun. 267: 609-613.
33. Springer, T. A. 1995. Immunoaffinity chromatography. In Current Protocols in Molecular Biology. F.M. Ausubel, R. Brent,R. E. Kingston, D. D.Moore, J.G. Seidman, J. A. Smith, and K. Struhl, eds. John Wiley & Sons, Inc., Hoboken, NJ, Vol. 2. p 10.11.1-10.11.6.
34. Michal, G. 1984. D-Fructose 1,6-Bisphosphate, Dihydroxyacetone Phosphate and D-Glyceraldehyde 3-Phosphate. Academic Press, New York.
35. Koeck, T., B. Levison, S. L. Hazen, J. W. Crabb, D. J. Stuehr, and K. S. Aulak. 2004. Tyrosine nitration impairs mammalian aldolase A activity. Mol. Cell. Proteomics 3: 548-557.
36. Xu, K., and J. L. Stringer. 2008. Pharmacokinetics of fructose-1,6-diphosphate after intraperitoneal and oral administration to adult rats. Pharmacol. Res. 57: 234-238.
37. Hohman, R. J., and S. C. Dreskin. 2001. Measuring degranulation of mast cells. Curr. Protoc. Immunol. Chapter 7:Unit 7.26.
38. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
39. Weljie, A. M., J. Newton, P. Mercier, E. Carlson, and C. M. Slupsky. 2006. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal. Chem. 78: 4430-4442.
40. Wishart, D. S., D. Tzur, C. Knox, R. Eisner, A. C. Guo, N. Young, D. Cheng, K. Jewell, D. Arndt, S. Sawhney, et al. 2007. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35(Database issue): D521-D526.
41. Hardin, C. D., and T. M. Roberts. 1994. Metabolism of exogenously applied fructose 1,6-bisphosphate in hypoxic vascular smooth muscle. Am. J. Physiol. 267: H2325-H2332.
42. Ehringer, W. D., W. Niu, B. Chiang, O. L. Wang, L. Gordon, and S. Chien. 2000. Membrane permeability of fructose-1,6-diphosphate in lipid vesicles and endothelial cells. Mol. Cell. Biochem. 210: 35-45.
43. Sekar, Y., T. C. Moon, S. Muñoz, and A. D. Befus. 2005. Role of nitric oxide in mast cells: controversies, current knowledge, and future applications. Immunol. Res. 33: 223-239.
44. Krumenacker, J. S., K. A. Hanafy, and F. Murad. 2004. Regulation of nitric oxide and soluble guanylyl cyclase. Brain Res. Bull. 62: 505-515.
45. Deschoolmeester, M. L., N. C. Eastmond, R. J. Dearman, I. Kimber, D. A. Basketter, and J. W. Coleman. 1999. Reciprocal effects of interleukin-4 and interferon-gamma on immunoglobulin E-mediated mast cell degranulation: a role for nitric oxide but not peroxynitrite or cyclic guanosine monophosphate. Immunology 96: 138-144.
46. Palazzolo-Ballance, A. M., C. Suquet, and J. K. Hurst. 2007. Pathways for intracellular generation of oxidants and tyrosine nitration by a macrophage cell line. Biochemistry 46: 7536-7548.
47. Takemoto, K., K. Ogino, D. H. Wang, T. Takigawa, C. M. Kurosawa, Y. Kamyabashi, Y. Hibino, Y. Hitomi, and H. Ichimura. 2007. Biochemical characterization of reactive nitrogen species by eosinophil peroxidase in tyrosine nitration. Acta Med. Okayama 61: 17-30. (Pubitemid 46423112)
48. Ulrich, M., A. Petre, N. Youhnovski, F. Promm, M. Schirle, M. Schumm, R. S. Pero, A. Doyle, J. Checkel, H. Kita, et al. 2008. Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase. J. Biol. Chem. 283: 28629-28640.
49. Klink, M., K. Bednarska, K. Jastrzembska, M. Banasik, and Z. Sulowska. 2007. Signal transduction pathways affected by nitric oxide donors during neutrophil functional response in vitro. Inflamm. Res. 56: 282-290.
50. Vassilakopoulos, T., K. Govindaraju, D. Parthenis, D. H. Eidelman, Y. Watanabe, and S. N. Hussain. 2007. Nitric oxide production in the ventilatory muscles in response to acute resistive loading. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1013-L1022.
51. Dukes, A. A., V. S. Van Laar, M. Cascio, and T. G. Hastings. 2008. Changes in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamine. J. Neurochem. 106: 333-346.
52. Arcelay, E., A. M. Salicioni, E. Wertheimer, and P. E. Visconti. 2008. Identification of proteins undergoing tyrosine phosphorylation during mouse sperm capacitation. Int. J. Dev. Biol. 52: 463-472.
53. Schindler, R., E. Weichselsdorfer, O. Wagner, and J. Bereiter-Hahn. 2001. Aldolase-localization in cultured cells: cell-type and substrate-specific regulation of cytoskeletal associations. Biochem. Cell Biol. 79: 719-728.
54. MacDonnell, P. C., and O. Greengard. 1974. Enzymes in intracellular organelles of adult and developing rat brain. Arch. Biochem. Biophys. 163: 644-655.
55. Mamczur, P., and A. Dzugaj. 2004. Nuclear localization of aldolase A in pig cardiomyocytes. Histol. Histopathol. 19: 753-758.
56. Heijnen, H. F., E. van Donselaar, J. W. Slot, D. M. Fries, B. Blachard-Fillion, R. Hodara, R. Lightfoot, M. Polydoro, D. Spielberg, L. Thomson, et al. 2006. Subcellular localization of tyrosine-nitrated proteins is dictated by reactive oxygen species generating enzymes and by proximity to nitric oxide synthase. Free Radic. Biol. Med. 40: 1903-1913.
57. Haqqani, A. S., J. F. Kelly, and H. C. Birnboim. 2002. Selective nitration of histone tyrosine residues in vivo in mutatect tumors. J. Biol. Chem. 277: 3614-3621.
58. Miller, S., C. Ross-Inta, and C. Giulivi. 2007. Kinetic and proteomic analyses of S-nitrosoglutathione-treated hexokinase A: consequences for cancer energy metabolism. Amino Acids 32: 593-602.
59. Lebherz, H. G., and W. J. Rutter. 1969. Distribution of fructose diphosphate aldolase variants in biological systems. Biochemistry 8: 109-121.
60. Yañez, A. J., H. C. Ludwig, R. Bertinat, C. Spichiger, R. Gatica, G. Berlien, O. Leon, M. Brito, I. I. Concha, and J. C. Slebe. 2005. Different involvement for aldolase isoenzymes in kidney glucose metabolism: aldolase B but not aldolase A colocalizes and forms a complex with FBPase. J. Cell. Physiol. 202: 743-753.
61. Takashi, M., H. Haimoto, T. Koshikawa, and K. Kato. 1990. Expression of aldolase C isozyme in renal cell carcinoma. Am. J. Clin. Pathol. 93: 631-636.
62. Miyagi, M., H. Sakaguchi, R. M. Darrow, L. Yan, K. A. West, K. S. Aulak, D. J. Stuehr, J. G. Hollyfield, D. T. Organisciak, and J. W. Crabb. 2002. Evidence that light modulates protein nitration in rat retina. Mol. Cell. Proteomics 1: 293-303.
63. Kanski, J., A. Behring, J. Pelling, and C. Schöneich. 2005. Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: effects of biological aging. Am. J. Physiol. Heart Circ. Physiol. 288: H371-H381.
64. Aulak, K. S., M. Miyagi, L. Yan, K. A. West, D. Massillon, J. W. Crabb, and D. J. Stuehr. 2001. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc. Natl. Acad. Sci. USA 98: 12056-12061.
65. Ghosh, S., A. J. Janocha, M. A. Aronica, S. Swaidani, S. A. Comhair, W. Xu, L. Zheng, S. Kaveti, M. Kinter, S. L. Hazen, and S. C. Erzurum. 2006. Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation. J. Immunol. 176: 5587-5597.
66. Parastatidis, I., L. Thomson, A. Burke, I. Chernysh, C. Nagaswami, J. Visser, S. Stamer, D. C. Liebler, G. Koliakos, H. F. Heijnen, et al. 2008. Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor. J. Biol. Chem. 283: 33846-33853.
67. Steinhagen-Thiessen, E., and H. Hilz. 1979. Aldolase activity and cross-reacting material in lymphocytes of aged individuals. Gerontology 25: 132-135.
68. Day, I. N., and R. J. Thompson. 1984. Levels of immunoreactive aldolase C, creatine kinase-BB, neuronal and non-neuronal enolase, and 14-3-3 protein in circulating human blood cells. Clin. Chim. Acta 136: 219-228.
69. Jean, J. C., C. B. Rich, and M. Joyce-Brady. 2006. Hypoxia results in an HIF-1-dependent induction of brain-specific aldolase C in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L950-L956.
70. Slemmer, J. E., E. D. Haasdijk, D. C. Engel, N. Plesnila, and J. T. Weber. 2007. Aldolase C-positive cerebellar Purkinje cells are resistant to delayed death after cerebral trauma and AMPA-mediated excitotoxicity. Eur. J. Neurosci. 26: 649-656.
71. Mesplès, B., R. H. Fontaine, V. Lelièvre, J. M. Launay, and P. Gressens. 2005. Neuronal TGF-beta1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice. Neurobiol. Dis. 18: 193-205.
72. Barreiro, E., R. Rabinovich, J. Marin-Corral, J. A. Barberà, J. Gea, and J. Roca. 2009. Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax 64: 13-19.
73. Madej, J. A., K. A. Sobiech, and S. Klimentowski. 1989. In vitro studies into some parameters of protein and carbohydrate metabolism in lymphocytes infected with bovine leucosis virus. Arch. Exp. Veterinarmed. 43: 923-927.
74. Takahashi, I., Y. Takasaki, and K. Hori. 1989. Site-directed mutagenesis of human aldolase isozymes: the role of Cys-72 and Cys-338 residues of aldolase A and of the carboxy-terminal Tyr residues of aldolases A and B. J. Biochem. 105: 281-286. (Pubitemid 19059089)
75. Kreuder, J., A. Borkhardt, R. Repp, A. Pekrun, B. Göttsche, U. Gottschalk, H. Reichmann, W. Schachenmayr, K. Schlegel, and F. Lampert. 1996. Brief report: inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. N. Engl. J. Med. 334: 1100-1104.
76. Sola, A., J. Roselló-Catafau, E. Gelpí, and G. Hotter. 2001. Fructose-1,6-biphosphate in rat intestinal preconditioning: involvement of nitric oxide. Gut 48: 168-175.
77. Hardie, D. G., and D. Carling. 1997. The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur. J. Biochem. 246: 259-273. (Pubitemid 27232500)
78. Carling, D. 2004. AMPK. Curr. Biol. 14: R220.
79. Sonnewald, U., T. B. Müller, N. Westergaard, G. Unsgård, S. B. Petersen, and A. Schousboe. 1994. NMR spectroscopic study of cell cultures of astrocytes and neurons exposed to hypoxia: compartmentation of astrocyte metabolism. Neurochem. Int. 24: 473-483.
80. Almeida, A., J. Almeida, J. P. Bolaños, and S. Moncada. 2001. Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc. Natl. Acad. Sci. USA 98: 15294-15299.
81. Almeida, A., S. Moncada, and J. P. Bolaños. 2004. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2- kinase pathway. Nat. Cell Biol. 6: 45-51.
82. Donohoe, P. H., C. S. Fahlman, P. E. Bickler, Z. S. Vexler, and G. A. Gregory. 2001. Neuroprotection and intracellular Ca2+ modulation with fructose-1,6-bisphosphate during in vitro hypoxia-ischemia involves phospholipase C-dependent signaling. Brain Res. 917: 158-166.
83. Cohly, H., J. Jenkins, T. Skelton, E. Meydrech, and A. K. Markov. 2004. Fructose-1,6-diphosphate suppresses T-lymphocyte proliferation, promotes apoptosis and inhibits interleukins-1, 6, beta-actin mRNAs, and transcription factors expression. Immunol. Invest. 33: 407-421.
84. Moresco, R. N., R. C. Santos, J. C. Alves Filho, A. A. Cunha, C. Dos Reis, C. L. Reichel, and J. R. De Oliveira. 2004. Protective effect of fructose-1,6-bisphosphate in the cold storage solution for liver preservation in rat hepatic transplantation. Transplant. Proc. 36: 1261-1264.
85. Markov, A. K. Treatment of asthma with fructose-1,6-diphosphate. U.S. Patent 5858985 1999 Jan 12
86. Cuesta, E., J. Boada, R. Calafell, J. C. Perales, T. Roig, and J. Bermudez. 2006. Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by D-galactosamine in rats. Crit. Care Med. 34: 807-814.
87. Yip, K., F. Leung, Y. Huang, and H. Lau. 2009. Inhibition of anti-IgE mediated human mast cell activation by NO donors is dependent on their NO release kinetics. Br. J. Pharmacol. 156: 1279-1286.
88. Gilfillan, A. M., and C. Tkaczyk. 2006. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6: 218-230.
89. Baron, C. B., S. Ozaki, Y. Watanabe, M. Hirata, E. F. LaBelle, and R. F. Coburn. 1995. Inositol 1,4,5-trisphosphate binding to porcine tracheal smooth muscle aldolase. J. Biol. Chem. 270: 20459-20465.
90. Koppitz, B., F. Vogel, and G. W. Mayr. 1986. Mammalian aldolases are isomerselective high-affinity inositol polyphosphate binders. Eur. J. Biochem. 161: 421-433.
91. Waingeh, V. F., C. D. Gustafson, E. I. Kozliak, S. L. Lowe, H. R. Knull, and K. A. Thomasson. 2006. Glycolytic enzyme interactions with yeast and skeletal muscle F-actin. Biophys. J. 90: 1371-1384.
92. Seo, I. R., S. H. Moh, E. H. Lee, G. Meissner, and do H. Kim. 2006. Aldolase potentiates DIDS activation of the ryanodine receptor in rabbit skeletal sarcoplasmic reticulum. Biochem. J. 399: 325-333.